Weiwei Zhu
- Oncology top 5%
- Global Cancer Incidence and Screening 6
- Cancer Research top 10%
- Breast Cancer Treatment Studies 5
- Cancer, Lipids, and Metabolism 5
- Cancer-related molecular mechanisms research 4
- Cancer, Hypoxia, and Metabolism 4
-
- Digital Radiography and Breast Imaging 8
- Immunology top 10%
-
- RNA modifications and cancer 6
-
- AI in cancer detection 6
Weiwei Zhu
57 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 119
- Oncology 561
- Cancer Research 292
- Pulmonary and Respiratory Medicine 436
- Immunology 217
- Molecular Biology 535
Countries citing papers authored by Weiwei Zhu
This map shows the geographic impact of Weiwei Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Zhu more than expected).
Fields of papers citing papers by Weiwei Zhu
This network shows the impact of papers produced by Weiwei Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Zhu. The network helps show where Weiwei Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weiwei Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 21 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 1 | |
| 10 | 2019 | 46 | |
| 11 | 2019 | 6 | |
| 12 | 2018 | 36 | |
| 13 | 2018 | 10 | |
| 14 | 2012 | 15 | |
| 15 | 2012 | 7 | |
| 16 | 2010 | 129 | |
| 17 | 2009 | 230 | |
| 18 | 2009 | 1 | |
| 19 | 2008 | 53 | |
| 20 | 2006 | 4 |
About Weiwei Zhu
Weiwei Zhu is a scholar working on Cancer Research, Nephrology and Emergency Medical Services, having authored 63 papers that have together received 1.6k indexed citations. Recurring topics across this work include Digital Radiography and Breast Imaging (8 papers), Global Cancer Incidence and Screening (6 papers), RNA modifications and cancer (6 papers), AI in cancer detection (6 papers), Breast Cancer Treatment Studies (5 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Oncology (561 citations), Cancer Research (292 citations) and Pulmonary and Respiratory Medicine (436 citations). Weiwei Zhu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Karla Kerlikowske, Daohai Yu, Anna N.A. Tosteson, Alan J. Korman, Jeffrey S. Weber, Roy Lau, Wenshi Wang, Diana L. Miglioretti, Brian L. Sprague and Jeffrey A. Tice. Their work appears in journals such as JAMA Network Open, Frontiers in Pharmacology, Biophysical Journal, Recent Patents on Anti-Cancer Drug Discovery and Medical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.